United Kingdom · Venture startup

Who invested in Vitarka Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2024, from 1 source

Latest round
VentureDec 2024
Investors
3
See who backed them

The rounds

  1. Dec 2024
    VentureAmount undisclosed

    Source recorded

Founders and team

From Vitarka Therapeutics's own website: 3 on the team.

  • Vineeta TripathiCEO
  • Agnes SzafranekHead of R&D Operations
  • John BeadleChairman

Everyone who backed them

SOSVVC firm1round
Innovate UKVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Vitarka Therapeutics

Who invested in Vitarka Therapeutics?

Vitarka Therapeutics's investors include SOSV, Innovate UK and Future Planet Capital.

How much has Vitarka Therapeutics raised?

Vitarka Therapeutics has raised 1 round since 2024, none with a disclosed amount.

When did Vitarka Therapeutics last raise?

Vitarka Therapeutics's most recent round was a Venture in Dec 2024.

Who backed Vitarka Therapeutics first?

Vitarka Therapeutics's first round on record, in Dec 2024, was backed by SOSV, Innovate UK and Future Planet Capital.

What stage is Vitarka Therapeutics at?

Vitarka Therapeutics's latest named round is a Venture, in Dec 2024.

Where is Vitarka Therapeutics based?

Vitarka Therapeutics is based in the United Kingdom.

Companies like Vitarka Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.